Pricing Log in Create free account

Molecular Partners AG Sponsored ADR (MOLN) vs Spruce Biosciences, Inc. (SPRB)

Molecular Partners AG Sponsored ADR and Spruce Biosciences, Inc. are both Biotechnology companies. Spruce Biosciences, Inc. is the larger, with a market value of $133.8M against $119.2M — 1.1× the size. Molecular Partners AG Sponsored ADR grew revenue faster over the last twelve months: −28.0% against −51.3%. Across the 13 metrics below, Spruce Biosciences, Inc. leads on 7 and Molecular Partners AG Sponsored ADR on 6.

Valuation

Metric MOLN SPRB Biotechnology median
P/E n/m n/m 10.60
P/S 21.86 23.04 9.40
P/B 1.98 1.35 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 9.32 4.88 9.02
Earnings yield (52.05%) (88.60%) (32.88%)
Free cash flow yield (45.19%) (37.80%) (23.13%)

Profitability

Metric MOLN SPRB Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (71.08%) (105.98%) (51.96%)
Return on assets (58.83%) (82.38%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MOLN SPRB Biotechnology median
Revenue growth (TTM) (27.99%) (51.32%) 6.76%
EPS growth (last fiscal year) (9.94%) 47.59% 29.88%
Revenue growth, 5-year CAGR (23.12%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MOLN SPRB Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 6.46 9.23 4.97
Net debt to EBITDA 1.66 1.34 1.01

Dividend

Metric MOLN SPRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MOLN SPRB Biotechnology median
Market cap 119.24m 133.79m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack